HTGM

HTG Molecular Diagnostics, Inc. [HTGM] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

HTGM Stock Summary

In the News

09:17 26 Feb 2024 HTGM

Why Is HTG Molecular Diagnostics (HTGM) Stock Down 42% Today?

HTG Molecular Diagnostics (NASDAQ: HTGM ) stock is falling on Tuesday after the company announced a Chapter 11 bankruptcy filing. According to this filing, HTG Molecular Diagnostics will operate as a “debtor-in-possession” business during the bankruptcy.

08:00 26 Feb 2024 HTGM

HTG Molecular Diagnostics Provides Highlights of its Second Event in Drug Discovery KOL Webcast Series

TUCSON, Ariz., Dec. 28, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, provides here a summary of its second HTG Therapeutics key opinion leader (KOL) webinar: “The Role of RNA Profiling in Drug Discovery and Analysis,” hosted on Tuesday, December 13, 2022.

10:57 26 Feb 2024 HTGM

What Is Going on With HTG Molecular Diagnostics (HTGM) Stock Today?

Some investors of HTG Molecular Diagnostics (NASDAQ: HTGM ) got a big surprise today. Due to a reverse share split, HTGM stock is suddenly more expensive.

01:00 26 Feb 2024 HTGM

3 Top Biotech Penny Stocks Under $3 To Watch Right Now

Biotech penny stocks to watch right now. The post 3 Top Biotech Penny Stocks Under $3 To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

11:51 26 Feb 2024 HTGM

Penny Stocks To Buy Now? 10 Stocks Under $1 To Watch

Penny stocks to watch trading under $1 right now. The post Penny Stocks To Buy Now?

06:00 26 Feb 2024 HTGM

How to Conduct Due Diligence on Penny Stocks, 3 Tips

Need help researching penny stocks to buy? Use these tips The post How to Conduct Due Diligence on Penny Stocks, 3 Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

02:51 26 Feb 2024 HTGM

7 Hot Penny Stocks Under $1 To Watch This Week

Penny stocks to watch trading under $1 right now. The post 7 Hot Penny Stocks Under $1 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

01:58 26 Feb 2024 HTGM

Three Small-Cap Biotech Stocks to Consider Now

This article looks at three small-cap biotech companies with stock prices that are making significant moves and have a bright outlook for 2023

11:18 26 Feb 2024 HTGM

Dear HTGM Stock Fans, Mark Your Calendars for Dec. 13

HTG Molecular Diagnostics (NASDAQ: HTGM ) stock is rocketing higher on Monday as investors prepare for a major event on Dec. 13. That's when the company will hold its HTG Therapeutics key opinion leader webinar.

08:01 26 Feb 2024 HTGM

HTG Molecular Diagnostics Announces the Next Event in its RNA Profiling in Drug Discovery KOL Webcast Series

TUCSON, Ariz., Dec. 09, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, today announced it will host its next HTG Therapeutics key opinion leader (KOL) webinar: “The Role of RNA Profiling in Drug Discovery and Analysis”, on Tuesday, December 13, 2022 at 11:00 am Eastern Standard Time.

HTGM Financial details

Company Rating
Buy
Market Cap
1.06M
Income
-20.15M
Revenue
6.21M
Book val./share
0.21
Cash/share
2.96
Dividend
-
Dividend %
-
Employees
53
Optionable
No
Shortable
Yes
Earnings
09 Aug 2023
P/E
-0.05
Forward P/E
-
PEG
0.01
P/S
0.17
P/B
2.24
P/C
-
P/FCF
-0.06
Quick Ratio
1.17
Current Ratio
1.4
Debt / Equity
8.39
LT Debt / Equity
0.89
-
-
EPS (TTM)
-18.89
EPS next Y
-
EPS next Q
-
EPS this Y
-18.14%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
100.46%
Revenue last 5Y
-21.61%
Revenue Q/Q
-57.67%
EPS Q/Q
-56.82%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
1%
ROA
-185%
ROE
-637%
ROC
-4.55%
Gross Margin
22%
Oper. Margin
-315%
Profit Margin
-324%
Payout
-
Shs Outstand
2.21M
Shs Float
2.11M
-
-
-
-
Target Price
0.16667
52W Range
0.462-24.96
52W High
-
52W Low
-
RSI
-
Rel Volume
2.86
Avg Volume
253.92K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.992605
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-

HTGM Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.9890.7322.1715.417.16
Net income per share
-0.75-91.17-54.12-29.66-24.28
Operating cash flow per share
-0.6-78.88-42.25-28.56-20.7
Free cash flow per share
-0.64-84.09-43.42-29.68-20.73
Cash per share
1.41156.0574.4137.9613.73
Book value per share
0.96113.2437.5617.996.06
Tangible book value per share
0.96113.2437.5617.996.06
Share holders equity per share
0.96113.2437.5617.996.06
Interest debt per share
0.4857.735.4422.16.4
Market cap
10.07B26.74M22.17M37.59M3.55M
Enterprise value
10.09B30.38M12.41M39.7M-3.83M
P/E ratio
-611.83-1.39-1.06-2.19-0.16
Price to sales ratio
468.151.392.594.220.56
POCF ratio
-764.16-1.6-1.36-2.28-0.19
PFCF ratio
-712.79-1.5-1.32-2.19-0.19
P/B Ratio
477.291.121.533.610.66
PTB ratio
477.291.121.533.610.66
EV to sales
469.261.581.454.46-0.6
Enterprise value over EBITDA
-716.66-1.83-0.69-2.030.19
EV to operating cash flow
-765.98-1.82-0.76-2.410.21
EV to free cash flow
-714.48-1.71-0.74-2.310.21
Earnings yield
0-0.72-0.94-0.46-6.09
Free cash flow yield
0-0.67-0.76-0.46-5.19
Debt to equity
0.460.470.871.130.9
Debt to assets
0.220.250.360.380.27
Net debt to EBITDA
-1.7-0.220.54-0.110.37
Current ratio
5.424.654.542.731.89
Interest coverage
-17.92-19.8-19.11-16.74-24.31
Income quality
0.80.870.780.960.85
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.930000
Research and developement to revenue
0.590.550.710.681.07
Intangibles to total assets
00000
Capex to operating cash flow
0.070.070.030.040
Capex to revenue
-0.04-0.06-0.05-0.070
Capex to depreciation
-0.65-0.64-0.34-0.89-0.04
Stock based compensation to revenue
0.090.060.210.150.13
Graham number
4.01481.98213.85109.5857.56
ROIC
-0.53-0.52-0.7-0.76-1.85
Return on tangible assets
-0.38-0.43-0.59-0.56-1.21
Graham Net
0.5870.3425.727.691.51
Working capital
30.98M32.47M25.63M17.24M7.38M
Tangible asset value
21.09M23.97M14.48M10.4M5.39M
Net current asset value
15.32M20.22M12.16M7.13M3.27M
Invested capital
0.460.470.871.130.9
Average receivables
5.68M4.09M2.38M1.84M1.76M
Average payables
2.14M1.76M1.51M1.5M1.4M
Average inventory
1.24M1.29M1.38M1.74M1.45M
Days sales outstanding
85.0860.1467.8385.7581.51
Days payables outstanding
132.6468.1123.34147.0292.4
Days of inventory on hand
93.6952136.45177.1872.59
Receivables turnover
4.296.075.384.264.48
Payables turnover
2.755.362.962.483.95
Inventory turnover
3.97.022.682.065.03
ROE
-0.78-0.81-1.44-1.65-4.01
Capex per share
-0.04-5.21-1.18-1.11-0.03

Quarterly Fundamentals Overview

Last date of statement is 2023-03-31 for Q1

Metric History 2022-03-312022-06-302022-09-302022-12-31 2023-03-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.771.631.362.740.47
Net income per share
-9.73-6.42-4.91-5.28-2.28
Operating cash flow per share
-8.9-6.38-4.99-2.28-1.97
Free cash flow per share
-8.91-6.39-5-2.28-1.97
Cash per share
32.315.387.0913.732.96
Book value per share
16.886.071.316.060.21
Tangible book value per share
16.886.071.316.060.21
Share holders equity per share
16.886.071.316.060.21
Interest debt per share
14.5610.156.795.631.86
Market cap
11.14M11.33M6.77M3.55M5.98M
Enterprise value
5.99M14.64M9.62M-3.83M6.96M
P/E ratio
-0.43-0.48-0.38-0.19-0.3
Price to sales ratio
9.47.65.421.455.79
POCF ratio
-1.87-1.94-1.47-1.75-1.37
PFCF ratio
-1.87-1.94-1.47-1.75-1.37
P/B Ratio
0.992.035.610.6612.6
PTB ratio
0.992.035.610.6612.6
EV to sales
5.069.827.69-1.576.74
Enterprise value over EBITDA
-0.99-2.58-2.30.87-1.39
EV to operating cash flow
-1.01-2.5-2.091.89-1.6
EV to free cash flow
-1.01-2.5-2.091.89-1.59
Earnings yield
-0.58-0.52-0.67-1.32-0.85
Free cash flow yield
-0.53-0.52-0.68-0.57-0.73
Debt to equity
0.841.635.010.98.39
Debt to assets
0.330.410.440.270.37
Net debt to EBITDA
0.85-0.58-0.681.67-0.2
Current ratio
2.991.91.581.891.4
Interest coverage
-25.09-23.8-21.69-27.02-36.22
Income quality
0.910.991.020.430.86
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
1.621.241.220.611.56
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
-0.010-0.010-0.01
Capex to depreciation
-0.05-0.04-0.060-0.07
Stock based compensation to revenue
0.230.160.140.060.13
Graham number
60.7929.6312.0426.833.32
ROIC
-0.3-0.38-0.52-0.4-0.94
Return on tangible assets
-0.23-0.27-0.33-0.26-0.47
Graham Net
8.9-0.67-4.681.51-1.2
Working capital
16.92M9.17M3.95M7.38M2.63M
Tangible asset value
11.27M5.57M1.21M5.39M474.5K
Net current asset value
8.22M2.69M-1.63M3.27M-1.2M
Invested capital
0.841.635.010.98.39
Average receivables
1.42M1M1.11M1.19M1.28M
Average payables
1.48M1.22M914.68K933.68K1.13M
Average inventory
2.01M1.99M1.82M1.3M782.12K
Days sales outstanding
56.9375.9769.152.4598.67
Days payables outstanding
138.6299.3195.2451.2785.92
Days of inventory on hand
212.88173.52226.7540.2851.27
Receivables turnover
1.581.181.31.720.91
Payables turnover
0.650.910.951.761.05
Inventory turnover
0.420.520.42.231.76
ROE
-0.58-1.06-3.74-0.87-10.65
Capex per share
-0.01-0.01-0.0100

HTGM Frequently Asked Questions

What is HTG Molecular Diagnostics, Inc. stock symbol ?

HTG Molecular Diagnostics, Inc. is a US stock , located in Tucson of Az and trading under the symbol HTGM

Is HTG Molecular Diagnostics, Inc. buy or a sell ?

1 stock analysts have 1 predictions with a medium analyst target price of $0.17. The lowest prediction is $0.16666666666667 and the highest is $0.16666666666667

What is HTGM stock prediction ?

What is HTG Molecular Diagnostics, Inc. stock quote today ?

HTG Molecular Diagnostics, Inc. stock price is $- today.

Is HTG Molecular Diagnostics, Inc. stock public?

Yes, HTG Molecular Diagnostics, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Similar Market Cap